leisure time -WSS

leisure time

author：focus 2025-09-28 01:34:35 - browse：46

Warning sign illustration made of 0s and 1s. -- first opinion coverage from sTAT — Adobe

Big businesses poised to profit from the advance of artificial intelligence in health care are pushing back against newly proposed federal rules meant to increase oversight and fairness of AI tools used to help make decisions about patient care.

The opposition, which includes Google and Amazon as well as large health care providers, insurers, and medical software vendors, is focused on an attempt to put tighter guardrails around the use of AI by the Office of the National Coordinator for Health Information Technology.

The agency wants to require developers of electronic health records and other health software to provide users with details about the training and testing of predictive models that draw data from their systems, or are hosted within them. It also wants developers to assess and publicly disclose potential risks and create a way for clinicians and other users to report problems.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

focus

hotspot

WSS

How dance can help nurses traumatized by Covid

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Google and Epic fight stronger regulation of AI in health care

Medicare drug price negotiation legal challenge met with skepticism

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

At Orexo, a ‘turning point’ for everything but digital health

focus

leisure time

focus

Guidelines to prevent youth baseball injuries need more muscle

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

23andMe had bad news about my health. I wish a person had delivered it

Key House panel plots a new health care package

How one medical school became remarkably diverse

AI can’t replace a physician’s gut feeling

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Group opposing PBM reform sets lobbying record

Virginia high school admissions case could be legal follow

Doctors find melanoma drugs effective against rare brain cancer

leisure time

Zyn nicotine pouches become unlikely player in latest culture war

Why you shouldn’t ask, “What country has the best health care?”

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Group opposing PBM reform sets lobbying record

Google and Epic fight stronger regulation of AI in health care

New clues to why women have higher risk of autoimmune disorders

focus

focus

hotspot

Wikipedia